Next Article in Journal
A Potential Daidzein Derivative Enhances Cytotoxicity of Epirubicin on Human Colon Adenocarcinoma Caco-2 Cells
Previous Article in Journal
Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(1), 146-157; doi:10.3390/ijms14010146

Modulation of P1 and EGF Expression by Baicalin

1
Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150036, China
2
School of Food Science and Engineering, Harbin Institute of Technology, Harbin 150090, China
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Received: 14 September 2012 / Revised: 7 December 2012 / Accepted: 10 December 2012 / Published: 20 December 2012
View Full-Text   |   Download PDF [568 KB, uploaded 19 June 2014]   |  

Abstract

Mycoplasma pneumoniae (M. pneumoniae) is increasingly recognized as a major cause of acute respiratory tract infections. Today, macrolides are used in the primary treatment of M. pneumoniae infection. However, with the increasing prevalence of strains resistant to macrolides, as well as reports of toxicity and adverse side effects, it is necessary to develop an alternative therapeutic agent. A compound recipe — Qinbaiqingfei pellets (Qinbai) — have already been approved in China as the first effective traditional Chinese medicine to be used against M. pneumoniae. Herein, we characterize the mechanism by which Qinbai interacts with M. pneumoniae and lung epithelial cells. The fact that Baicalin is the key component of Qingbai leads us to believe its study is important to elucidating the mechanism of the action of Qinbai. In this study, we describe the complex impact of Baicalin on the adhesin protein P1 of M. pneumoniae and on the expression of epidermal growth factor (EGF) in BALB/c mice and A549 cells infected with M. pneumonia. We draw the conclusion that Baicalin not only cured M. pneumoniae infection by inhibiting P1 expression, but also enhanced the repair of lung epithelial cells by upregulating EGF. Finally, we demonstrate that Baicalin plays a role in Qinbai treatment. View Full-Text
Keywords: M. pneumoniae; Baicalin; EGF; P1 M. pneumoniae; Baicalin; EGF; P1
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Meng, Y.; Huo, J.; Lu, W.; Wang, X.; Zhang, J.; Wang, W. Modulation of P1 and EGF Expression by Baicalin. Int. J. Mol. Sci. 2013, 14, 146-157.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top